Sort   by:  
 Page size 
UnknownA Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors.
Not available
S-EPMC11505462 | biostudies-literature
UnknownTrop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls.
Not available
S-EPMC8620404 | biostudies-literature
UnknownSacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.
Not available
S-EPMC9073799 | biostudies-literature
UnknownProgress with palbociclib in breast cancer: latest evidence and clinical considerations.
Not available
S-EPMC5298405 | biostudies-literature
UnknownExploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity.
Not available
S-EPMC11731316 | biostudies-literature
UnknownEmerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance.
Not available
S-EPMC8920988 | biostudies-literature
UnknownClinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.
Not available
S-EPMC6124791 | biostudies-literature
UnknownTumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota.
Not available
S-EPMC9845623 | biostudies-literature
UnknownHuman papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro.
Not available
S-EPMC11625066 | biostudies-literature
UnknownAndrogen receptor in breast cancer: The "5W" questions.
Not available
S-EPMC9468319 | biostudies-literature
Sort   by:  
 Page size